1. The effects of allyl-substituted compounds have been tested against a spectrum of 15 tumors of the mouse.
2. Among the series of 85 allyl-substituted compounds tested, 2-allylimino-1, 3, 4-thiadiazoline hydrochloride showed the most anti-tumor activity. At daily doses of 100mg/kg it had a moderate inhibitory effect on Miyono adenocarcinoma, Carcinoma 1025, Wagner and Ridgway osteogenic sarcomas, Gardner lymphosarcoma, and Harding-Passey melanoma. and a slight inhibitory effect on Sarcoma 180, Sarcoma MA 387, Ehrlich carcinoma, Bashford carcinoma 63, Adenocarcinoma E0771, Lewis bladder carcinoma, Lewis lung carcinoma, and Glioma 26.
3. N-Allyl-
p-toluene sulfonamide,
p-allylaminoazobenzene, and 4-allylthiosemicarbazide had a moderate inhibitory effect on Sarcoma 180; allylguaiacyl ether had a moderate inhibitory effect on Bashford carcinoma 63; 6-allyl-
o-aminophenol•HCl had a moderate inhibitory effect on Carcinoma 1025; 4-allylaminophenylacetonitrile and N, N′-diallyl-
o-tolidine had a moderate inhibitory effect on Ridgway osteogenic sarcoma; and 2-(γ-chloroallylimino)-1, 3, 4-thiadiazoline had a moderate inhibitory effect on Harding-Passey melanoma.
View full abstract